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ABSTRACT Spleen focus-forming virus-transformed
erythroleukemic cell clones, which have been established
by infection ofN type mice withNB tropic Friend virus, con-
tinue to release biologically active Friend virus of NB host
range. Dimethylsulfoxide induces erythroid differentiation
and a 10- to 100-fold increase in the release of biologically
active Friend virus. The increase of Friend virus release is a
function of the differentiating erythroleukemic cell. The
induced Friend virus is not the NB tropic Friend virus com-
plex, but shows N host range. The induction of the Friend
virus complex is due to simultaneous induction of both
spleen focus-forming and endogenous viruses.
Mouse erythroleukemia cells in culture offer an opportunity
to study the role of the erythroid cell-transforming spleen
focus-forming virus (SFFV) during dimethylsulfoxide (Me2-
SO)-induced erythroid differentiation of these cells. Dif-
ferentiation is blocked by viral transformation; the block can
be released specifically by aprotonic solvents (1-3) or by
steroids (4). There are two viral components in the Friend
virus (FV) complex, the SFFV and a helper virus (LLV-F)
(5, 6). The LLV-F can be replaced as helper virus by other C
type viruses (6, 7) or by an endogenous virus which is in-
ducible by BrdU (8).
In this paper we show that Me2SO, which induces erythroid
differentiation in culture, also induces parallel release of an
endogenous C type virus and SSFV. This induction is cor-
related in time with the induction of globin mRNA synthesis
in the same cell (9). The release of the block of differentiation
which is normally exerted by the SFFV, and the induction of
endogenous N tropic and transforming virus but not of the
original NB tropic helper virus during differentiation, can be
used to study the interaction and normal function of both the
endogenous virus and SFFV during differentiation and trans-
formation.
MATERIALS AND METHODS
Tissue Culture. The origin (DBA/2 mice, NB tropic Balb/c
adapted FV complex) and maintenance of the erythroleu-
kemic cell clone FSD1/F4 (=F4), as well as of the BrdU-
Abbreviations: FV, Friend virus complex; SFFV, spleen focus-
forming virus; LLV, lymphatic leukemia virus; LLV-F, lym-
phatic leukemia virus of the Friend virus complex; Me2SO,
dimethylsulfoxide.
§ Present address: California Institute of Technology, Division
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resistant, TK- subelone F4/B8 (= B8) have been described
(2, 10). F4 has been kept permanently in culture for 4 years
now. This line has been called F4A. After 4 years of continuous
growth, F4A, after being passaged at a high cell density,
largely lost the capacity to be induced by Me2SO. This subline
is F4AO. Because of noninducibility of F4AO, we are now
using the original cell clone F4, which has been kept frozen for
almost 4 years, F4N (9). Cell Clone M2 is a subelone of Friend
cell clone 707 (1, 11). The origin and properties of the FV
(SFFV)-transformed cell lines are shown in Table 1. The cell
lines are free of mycoplasma contamination.
Induction of Differentiation. Me2SO was added at 1-1.5%
at day 0 to logarithmically growing cells at a density of 5 X
105-1 X 108 cells per ml. Part of the medium and cells were
discarded at day 2 of exposure to Me2SO and new medium
containing Me2SO was added to maintain a constant cell
density of about 1 X 106 cells per ml. The degree of differentia-
tion was measured by the synthesis of hemoglobin 4-5 days
after the inducer was added (2).
Virus Assay. C type virus release was measured by the XC
assay (12) with fetal Balb/c (A31) indicator cells (8). For
each XC assay, serial 1: 5 dilutions were made. One T75 flask
was used for each step. Experiments were repeated at least
twice. The release of transforming SFFV and of helper virus
was determined by spleen focus formation in 2- to 6-month-
old DBA/2 or Balb/c mice (13). The filtered tissue culture
supernatants were serially diluted 1/3 in a 2% serum contain-
ing buffer solution (8). Three mice were-used for each dilution.
Each experiment was repeated at least once.
Titration of SFFV by LLV-F. NB tropic, Balb/c adapted
LLV-F (NB) was obtained through the courtesy of Dr.
Steeves (Albert Einstein College of Medicine, New York).
LLV-F was propagated in newborn Balb/c mice. The titer
of LLV-F was checked by the XC assay. 1 X 107 plaque-
forming units of NB tropic LLV-F were added to virus ob-
tained from tissue culture supernatant and injected into the
lateral tail vein of DBA/2 or Balb/c mice.
Large-Scale Isolation of Virus. F4 cells were grown to a
density of 2 X 106 cells per ml in roller cultures. Cells were
collected by centrifugation and new medium was added. The
supernatant was removed serially to collect virus. Virus was
precipitated by (NH4)2SO4 and separated from contaminants
by banding the virus in a discontinuous sucrose gradient and
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TABLE 1. Friend virus-transformed cell lines, hemoglobin synthesis, spleen focus-forming virus release, and thymidine kinase activity
Clone or % Globin SFFV/106 cellSb Origin of Thymidine
subelone Treatment synthesis- in DBA/2 mice in Balb/c mice cell line kinasec
F4A Uninduced <1.1 1.2 X 104 1.0 X 104 4 years tissue cul- +++
1.5% Me2SO 25 2 X 105-1.2 X 106 Not done ture F4
F4N Uninduced <0.8 800-1500 1000-1600 1 year tissue cul- +++
1% Me2SO 25.3 2 X 104-1 X 105 600-1200 ture F4
1.5% Me2SO 21.5 5 X 103-2 X 104 Not done
F4AO Uninduced <1.0 8 X 103-1 X 104 Not done Derived from F4A, +++
1% Me2SO <1.2 8 X 103 Not done 5 years tissue
1.5% Me2SO 1.8 1 X 104 Not done culture
M2 Uninduced 2.5 0 Not done Subelone of clone ++ +
1.5% Me2SO 26.0 0 Not done 707 (C. Friend)
B8 Uninduced 2.2 1-5 0-3 Subclone of F4A 4
1.5% Me2SO 23.5 0-3 Not done i
0.6 mM 6 1-8 X 103 10-100 BrdU-resistant ++
BrdU
The % globin synthesis is deduced by the amount of [14C]_ or [3H]leucine label under the a and fl globin peaks separated by carboxy-
methylcellulose/urea column chromatography. This value is expressed as % of the total hot trichloroacetic acid-precipitable, 0.5%
Nonidet-P40-soluble cytoplasmic leucine label in the cells. All experiments have been repeated at least once, some up to 10 times. The
range of values that was obtained in different experiments with virus release is indicated. The % globin synthesis in different experi-
ments has been averaged.
* Globin synthesis is determined at day 4-5 of Me2SO or BrdU treatment with treated cells.
b Spleen focus-forming units of treated cell during optimal induction by Me2SO or BrdU.
o Thymidine kinase activity was determined as described, and the thymidine kinase activity of different cell lines is published (8, 10).
by two sucrose density gradient centrifugations (14, 15).
About 25 /Ag of 60-70S RNA was obtained from the super-
natant of 2 X 1010 cells.
Labeling of Viral RNA. Cells were labeled with carrier-
free 32p (0.5 mCi/ml) in phosphate-free medium with 1.5%
Me2SO 20-24 and 24-36 hr after Me2SO was added. Virus
was separated as described above, and viral RNA was ex-
tracted (15). Thirty to 35S RNA was obtained by heating the
total viral RNA for 45 sec at 1000 (15). This RNA, together
with unlabeled viral RNA, was applied to 2.2% acrylamide
slab gels (2). After electrophoresis, the slab gels were exposed
to x-ray films, and the 30-35S region and the regions corre-
sponding to 8-16 S, where globin mRNA should separate,
were eluted. This RNA, as well as the RNA obtained by
sodium dodecyl sulfate/sucrose density gradients, was used
for globin cDNA hybridization experiments.
Globin cDNA and Globin cDNA Hybridization. Globin
mRNA isolated from reticulocytes of white Swiss (ICI)
mice was used for preparing cDNA. Globin cDNA was pre-
pared and purified (16). We used a titration technique in
which a fixed amount of globin cDNA (1 ng) is annealed at
430 with increasing amounts of RNA in hybridization buffer
TABLE 2. Increase of FV release by Me2SO-stimulated F4N
cells. 82p label in virions
32p cpm
released Relative
per hr values
Control (4 hr) 70,000 1
1.5% Me2SO 20-24 hr 75,000 1.07
1.5% Me2SO 24-36 hr 600,000 8.6
F4N cells were labeled as described in Materials and Methods.
(0.5 M NaCl, 25 mM Hepes, 1 mM EDTA, 50% formamide,
pH 6.7) (17). The concentration of globin mRNA in the RNA
is deduced by comparing the initial slope of its titration plot
with that of globin mRNA.
After hybridization for 72 hr, hybrid was detected by re-
sistance to single-stranded nuclease (Si) (18). The number of
globin mRNA sequences per viral genome is calculated from
the percent of viral RNA comprising globin mRNA, allowing
for the 50-fold increase in molecular weights of viral RNA
relative to globin mRNA.
RESULTS
Induction of Globin Synthesis. When cells of F4A F4N, or
M2 are induced by 1-1.5% Me2SO, 20-25% of the total hot
trichloroacetic acid-precipitable, 0.5% Nonidet-P40-soluble
material labeled with leucine is globin at day 4-5, while sub-
line F4AO does not show induction of globin synthesis (Table
1).
Induction of Virus Release in Erythroid Differentiating
Cells. One or 1.5% Me2SO, if added to F4N cells, induces dif-
ferentiation and a 10- to 100-fold increase in spleen focus
formation of the FV complex (Fig. la and Table 1). The same
increase is obtained if F4A cells are used (19, 20). F4A has a
10-fold higher spontaneous virus titer than F4N. The relative
virus and globin induction rate, however, is the same (refs.
19 and 20 and this paper). This increase parallels in time the
appearance of newly labeled globin mRNA (9, 19). The in-
crease in virus production during the first 2 days of Me2SO
induction is confirmed by an 8.6-fold increase in the 32p label
of virions (Table 2) and by a 6.5-fold increase in viral RNA by
absorbance measurements (Table 3). The discrepancy be-
tween the increase in biological titer and the physical measure-
ments can be explained by our observations that the yield of
intact 30-35S RNA relative to 70S RNA is increased after
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TABLE 3. Increase of FV release by Me2SO-stimulated
F4N cells
A2W0 viral
RNA released Relative
per hr values
Control (7 hr) 2 1
1% Me2SO (-16 hr) 3.5 1.7
1% Me2SO (16-25 hr) 9 4.5
1% Me2SO (25-36 hr) 13 6.5
/| ~~0 \ F4N cells (lOL) were grown to a density of 2 X 106 cells per
/ '\ \ ml in Roller cultures. Cells were centrifuged. New medium (5L)
1 'X3A ' \ I was added and incubation continued for 7 hr. After 7 hr, cells
were pelleted. The supernatant was removed to collect virus.
Incubation of the cells was continued with fresh medium con-
taining 1% Me2SO for successive time periods with medium
exchange as indicated in column 1. Virus was separated by the
usual methods and viral RNA prepared. The relative values are
\/t~->\ corrected for cell numbers.
Me2SO stimulation. Degradation of the 70S RNA is decreased
102.,
after stimulation and biological activity increased as a re-
sult (19). The induction and release of the FV complex in dif-
ferentiating cells is temporary and precedes the time of maxi-
mum globin synthesis. After 2-3 days of exposure to Me2SO a
'% >steep drop in virus release is detected, and after 5-6 days cells
\ of . 104 release less virus than untreated cells.
^~~~~~v) 1 2 3 4 5 \ 6 7 8 days Me2SO Induction of Virus Release Js Dependent on Erythroid Dif-Luniduced tGx102 ferentiation. In order to show that Me2SO alone is not re-
sponsible for the increase in virus titers, we used the subline
SFFU/lO6cells XC units\lo6ce~ls F4AO of cell clone F4. F4AO does not respond and dif-
ferentiate as the parent cell line does in the presence of Me2SO.
b F4AO These cells were exposed to 1 or 1.5% Me2SO. The data are
shown in Fig. lb and Table 1. No increase in the number of
spleen focus-forming units is observed.
The Virus Induced by Mle2SO in Differentiating Cells Is Not
NB Tropic FV but an N-Tropic Endogenous FV Complex.
o06.. To determine the host range of the Me2SO-induced virus com-
plex, we injected the supernatant from noninduced (0 point of
Fig. 2) and of Me2SO-induced cells into the tail vein of N type
DBA/2 and B type Balb/c mice (Fig. 2). The data show that
the FV complex released by uninduced F4 cells is indeed NB
tropic since no marked difference in spleen focus formation in
10\ foBalb/c or mice could be detected (Fig. and Table 1).._FV complex released by induced cells is, however, almost
_exclusively N tropic (Fig. 2) since a 20-fold increase in spleen105 focus formation was obtained in N type DBA/2 mice, but no
103 . detectable increase 'over the titer observed in uninduced cells
was found in B type Balb/c mice. This conclusion was con-
firmed in a second series of experiments when only a marginal
increase in plaque formation in the XC B type cell assay was
found, whereas the same sample elicited a 60- to 80-fold in-
crease in spleen foci in N type mice (Fig. la). The slight 2-
fold increase in the XC assay at day 2 of Me2SO exposure is
10'
Me2SO (Table 1). They show a 60- to 80-fold increase in virus
O 1 2 3 4 6 7 a days release with spleen focus formation. *, 1% Me2SO, SFFU;
- uninduced Me2SO 0, 1.5% Me2SO, SFFU; X, 1% Me2SO, XC; A, 1.5% Me2SO,
FIG. 1. Induction of virus release in erythroid differentiating XC. (b) F4AO cells do not differentiate on exposure to Me2SO
cells as determined by spleen focus-forming units in N type (Table 1). They do not show an increase in virus release with
DBA/2 mice. The increase in virus release is the same if medium spleen focus formation. 0, 1% Me2SO, SFFU; *, 1.5% Me2SO,
is exchanged daily (20). (a) F4/N cells differentiate on exposure to SFFU; X, 1% Me2SO, XC; A, 1.5% Me2SO, XC.
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(B)+ LLV-F(NB)
( N)+ LLV-F(NB)
'ABalb/c (B)
0 (uninduced) 1 2 days 1% Me2SO
FIG. 2. The host range of the virus of noninduced F4N cells
is NB as shown by equal numbers of spleen foci induced in N
type DBA/2 and B type Balb/c mice (0 point df curve). Other
values are with 1% Me2SO. This shows the N-tropism of the
induced endogenous helper virus. Titration of SFFV with NB
tropic LLV: 0, spleen foci in N type DBA/2 mice; 0, spleen
foci in N type DBA/2 .mice, 107 XC units NB tropic LLV-F
added; A, spleen foci in B type Balb/c mice; A, spleen foci in
B type Balb/c mice, 107 XC units NB tropic LLV are added.
probably due either to the protective properties of Me2SO of
virions in Me2SO-containing medium or to the incomplete
resistance of B type mice to N tropic virus. We conclude that
the induced virus is not the NB-tropic helper virus of unin-
duced cells, but an N-tropic endogenous virus. The yield of
Me2SO-induced endogenous virus in F4 cells is very high,
much higher than that obtained by BrdU treatment of normal
mouse fibroblasts (21) or TK- erythroleukemia cells (8).
SFFV Is Increased in Differentiating F4 Cells. To determine
whether the induced virus is exclusively N tropic endogenous
virus or also SFFV, we need to know whether the helper virus
or the SFFV is limiting in the spleen focus formation. We
therefore added to the cell supernatant excess NB tropic
LLV-F. The data are shown in Fig. 2. LLV-F does not in-
crease the number of spleen foci in N type DBA/2 mice.
Added NB tropic LLV-F does not increase the number of
spleen focus-forming units released by either uninduced (0
point of curve of Fig. 2) or induced F4 cells (Fig. 2). The in-
duction of virus in MIe2SO-exposed cells is therefore not only
an induction of N tropic endogenous virus, but also of SFFV.
The titer of SFFV is raised in B type Balb/c mice if NB
tropic LLV-F is added to the viral supernatant. The increase
of spleen focus-forming units in B and N type mice is then
identical.
TABLE 4. Globin mRNA sequences in Friend virus RNA of
virus released during Me2SO induction
Viral % Globin
RNA mRNA
Total 0.004
60-70S 0.009
9-14S 0.0023
30-35S <0.0001
RNA was prepared and hybridizations were performed as
described in Materials and Methods.
Globin mRNA Sequences in the FV Complex. Conflicting
results concerning the presence of globin mRNA in FV
released by SFFV-transformed cells have been reported for
two different cell lines (11, 22). We have re-examined this
question both with the Friend M2 cell line (11) and with F4.
We have used virions released during a 7-hr period of 1%
Me2SO stimulation in order to avoid the use of old virions that
contain 70S RNA with internal single-strand breaks (23).
No globin mRNA sequences were obtained in M2 virus,
whereas some globin mRNA sequences were detected in viral
RNA from 1\ie2SO-stimulated F4 cells (Table 4). However,
these sequences are largely (72%) in the 9-14S region, where
globin mRNA should appear, with only a small amount (28%)
in the 60-70S RNA (Table 4). The data for 60-70S RNA cor-
respond to approximately one globin mRNA sequence per
10,000 viral genomes. No sequences complementary to globin
cDNA were found in 30-35S viral RNA after melting and
fractionation of the 70S RNA on acrylamide gels (Table
4).
l25I-Labeled globin mRNA was hybridized to viral RNA to
detect sequences complementary to globin mRNA. At ratios
of viral RNA to globin mRNA of up to 5000:1, only 2.6%
hybrid was observed (the background level for this assay),
although in a control experiment the 1251-labeled mRNA was
rendered 60% resistant to RNase treatment in the presence
of excess globin cDNA. We conclude that no "anti-strands"
to globin mRNA exist in the viral genome. We, therefore,
believe that the association between mRNA and viral RNA
observed by other investigators (22) and observed by us to a
much lesser extent, is noncovalent and artifactual.
A considerable proportion (10-20%) of the RNA isolated
from preparations of Friend virus is ribosomal RNA (ref. 19
and Pragnell and Crossley, unpublished). Ribosomal RNA in
C type virus has been ascribed to the presence of host ribo-
somes fortuitously trapped in budding virions (24). These
ribosomes in Me2SO-induced cells may contain globin mRNA
which might artifactually bind to the 60-70S RNA, especially
if the virus particles contain nicked exposed 60-70S RNA, as
would be the case in 4- to 5-day-old virions.
DISCUSSION
The fact that there is no virus induction in a clone of SFFV-
transformed cells that do not undergo erythroid differentiation
when exposed to Me2SO indicates that the increased release of
virus observed in the F4 parent cell lines is dependent upon
erythroid differentiation taking place. However, induced
release of a C type virus is not a prerequisite for differentiation
of SFFV-transformed cells. We have described several BrdU-
resistant, TK-, SFFV-transformed cell lines that do not re-
Proc. Nat. Acad. Sci. USA 72 (1975)
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lease C type particles spontaneously or on exposure to MJ~e2SO,
but nevertheless synthesize hemoglobin (8) (Table 1). Simi-
larly, F4 cells treated with interferon or with a thymidine
analogue, azidothymidine, together with Me2SO do dif-
ferentiate but release 50- to 100-fold less virus than cells that
were treated with \e2SO alone (9, 19, 20). However, a 10- to
20-fold increase in intracisternal virus-like A particles is found
during differentiation of "virus-negative" 138 cells and during
inhibition of virus release during differentiation of virus-
positive F4 cells (19).
We have shown that the FV complex that is induced by
Me2SO is N-tropic, whereas the virus released by uninduced
cells is NB3 tropic (Fig. 2 and Table 1). Therefore, the virus
induced as a result of Me2SO-stimulated differentiation of F4
cells is not the NB tropic helper virus of uninduced cells but
an endogenous N-tropic helper virus. In some experiments, a
2- to 5-fold increase in focus-forming units even in 13 type
mice can initially be observed. This is probably a reflection of
the excess of NB helper virus. At higher MXe2SO concentra-
tions or with lower cell densities, we usually obtain a steep
decline of the NB tropic helper as compared to that released
by uninduced cells.
We here report induction of an endogenous virus during
differentiation, in contrast to induction by IdU or BrdU
(21, 8), radiation (25), or activation by relaxation of immune
mechanisms (26). The induction of virus in the FV complex is
not restricted to the endogenous virus. An increased number
of transforming SFFV are released as well, as shown by the
same increase in spleen focus formation in N type mice re-
gardless of the number of externally added NB tropic LLV-F.
Accordingly, the increase in spleen focus formation was also
obtained with B type Balb/c mice if excess NB tropic LLV-F
as a helper was added (Fig. 2).
The joint induction of both endogenous and SFFV virus
could also mean that the transformed cells release a non-
defective endogenous virus with the ability to transform
erythroid cells. These data indicate that the endogenous virus
and the erythroid focus-forming virus interact during Me2SO-
induced erythroid differentiation.
Let us assume that the endogenous virus that can be induced
by BrdU in TK-, B8 cells (8) (Table 1) is the same in dif-
ferentiating TK+, F4 cells. Then the most likely explanation
of the lack of inducibility of endogenous virus in TK-,
"virus-negative," SFFV-transformed cells during MXe2SO-
induced differentiation seems to us to be that the presence of
thymidine kinase activity is needed during induced differentia-
tion to rescue endogenous virus. Thymidine kinase activity
is present in TE:+, F4 cells and can be induced by BrdU but
not by Me2SO in the inducible TK -, B8 cells (8) (Table 1).
Note Added in Proof: We have now isolated a Balb/c SFFV-
transformed virus negative cell line, FLD-3, which, on exposure
to Me2SO releases a large titer of endogenous SFFV.
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